Literature DB >> 7057801

Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line.

G Jasmin, L Proschek.   

Abstract

The Syrian hamster polymyopathy is a hereditary disease, transmitted by an autosomal recessive gene, involving the heart and the entire musculature. The chronology of the pathologic events in the myocardium and skeletal muscle has been investigated in UM-X7.1 myopathic hamsters aged 0-250 days. A phasic pattern in the progression of the disease process was evident. Microscopic necrotic changes in the heart were visible prior to or at 50 days of age with increasing severity until 100 days of age and subsidence thereafter. More than 50% of the animals died before 250 days of age with signs of cardiac failure. The intensity and extent of myocardial calcific changes together with scar formation were determinant factors in curtailing the survival of animals. Changes in serum creatine kinase (CK) activity followed a phasic pattern similar to the progression of the myopathic disease. Because of the disparity of disease manifestations between the different myopathic hamster lines, it is essential to consider the time course of the heart and skeletal muscle microscopic changes when evaluating the severity of the hamster polymyopathy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057801     DOI: 10.1002/mus.880050105

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  17 in total

1.  Delta-sarcoglycan gene therapy halts progression of cardiac dysfunction, improves respiratory failure, and prolongs life in myopathic hamsters.

Authors:  Masahiko Hoshijima; Takeharu Hayashi; Young E Jeon; Zhenxing Fu; Yusu Gu; Nancy D Dalton; Mark H Ellisman; Xiao Xiao; Frank L Powell; John Ross
Journal:  Circ Heart Fail       Date:  2010-10-29       Impact factor: 8.790

2.  Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor.

Authors:  Shusaku Miyata; Genzou Takemura; Yukinori Kawase; Yiwen Li; Hideshi Okada; Rumi Maruyama; Hiroaki Ushikoshi; Masayasu Esaki; Hiromitsu Kanamori; Longhu Li; Yu Misao; Asaki Tezuka; Teruhiko Toyo-Oka; Shinya Minatoguchi; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  The cardiomyopathic hamster as model of early myocardial aging.

Authors:  M Minieri; R Fiaccavento; L Carosella; G Peruzzi; P Di Nardo
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

4.  Modification of aortic contractility in the cardiomyopathic hamster.

Authors:  E C Dumont; C Lambert; D Lamontagne
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

Review 5.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

6.  Alterations in G-proteins in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters.

Authors:  R Sethi; N Bector; N Takeda; M Nagano; G Jasmin; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

7.  Reduction of ventricular M2 muscarinic receptors in cardiomyopathic hamster (CHF 147) at the necrotic stage of the myopathy.

Authors:  M Wilkinson; M Horackova; A Giles
Journal:  Pflugers Arch       Date:  1994-04       Impact factor: 3.657

8.  Myocardial expression of atrial natriuretic factor gene in early stages of hamster cardiomyopathy.

Authors:  P Di Nardo; M Minieri; A Carbone; N Maggiano; R Micheletti; G Peruzzi; G Tallarida
Journal:  Mol Cell Biochem       Date:  1993-08-25       Impact factor: 3.396

9.  Kinetic changes of ethanolamine base exchange activity and increase of viscosity in sarcolemmal membranes of hamster heart during development of cardiomyopathy.

Authors:  A Vecchini; L Binaglia; P Di Nardo; M Bartoli; M Minieri; G Tallarida
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

10.  ANF in experimental congestive heart failure.

Authors:  M Cantin; G Thibault; J F Ding; J Gutkowska; R Garcia; G Jasmin; P Hamet; J Genest
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.